Higher HDL Cholesterol in Statin Therapy, Key to Slowing Atherosclerosis?

March 2007
Travel Medicine Advisor;Mar2007, Vol. 17 Issue 3, p1
The article discusses a study which revealed that higher high density lipoproteins (HDL) cholesterol in statin therapy may be linked with progression and regression of atherosclerosis. The largest decline in atheroma volume was linked with patients with low density lipoprotein cholesterol less than a mean of 87.5 milligram/dl and percentage increases in HDL cholesterol of greater than 7.5%.


Related Articles

  • High Density Lipoprotein and it's Dysfunction. Eren, Esin; Yilmaz, Necat; Aydin, Ozgur // Open Biochemistry Journal;2012, Vol. 6, p78 

    Plasma high-density lipoprotein cholesterol(HDL-C) levels do not predict functionality and composition of high-density lipoprotein(HDL). Traditionally, keeping levels of low-density lipoprotein cholesterol(LDL-C) down and HDL-C up have been the goal of patients to prevent atherosclerosis that...

  • Drugs that change cholesterol levels.  // Consumer Reports on Health;Sep2004, Vol. 16 Issue 9, p7 

    Lists several drugs that change low density lipoprotein and high density lipoprotein cholesterol level in the U.S.

  • Efectos de la combinaci�n de ezetimiba m�s estatinas sobre los l�pidos en pacientes mexicanos. Jaime Carranza Madrigal; Cort�s, Angelina Herrera; Colunga, Hugo Lemus // Medicina Interna de Mexico;jul/ago2007, Vol. 23 Issue 4, p280 

    Background: The percentage of patients treated with statins who reach the low-density lipoproteins cholesterol goal is low. Objective: This trial was designed to determine the effects of ezetimiba plus statins on lipid profile from Mexican patients with LDL-C values above the goal. Methods:...

  • Cholesteryl ester transfer protein and its inhibition. Weber, Olaf; Bischoff, Hilmar; Schmeck, Carsten; Böttcher, Michael-Friedrich // Cellular & Molecular Life Sciences;Sep2010, Vol. 67 Issue 18, p3139 

    Cholesteryl ester transfer protein (CETP) is a plasma glycoprotein that facilitates the transfer of cholesteryl esters from the atheroprotective high density lipoprotein (HDL) to the proatherogenic low density lipoprotein cholesterol (LDL) and very low density lipoprotein cholesterol (VLDL)...

  • Controlling Multiple Risk Factors Has a Cumulative Effect on Prevention of Recurrent Stroke. Spittler, Karen L. // Neurology Reviews;Jun2009, Vol. 17 Issue 6, p6 

    The article offers information on the study which investigates that optimal levels of low-density lipoproteins (LDL) cholesterol, high-density lipoproteins (HDL) cholesterol, triglycerides and blood pressure. It notes that LDL and HDL, as well as cholesterol and triglycerides reduce a person's...

  • Quantification of Low-Density and High-Density Lipoproteins in Human Serum by Material Enhanced Infrared Spectroscopy (MEIRS). Petter, C. H.; Heigl, N.; Bakry, R.; Bonn, G. K.; Ritsch, A.; Huck, C. W. // Current Medicinal Chemistry;Dec2009, Vol. 16 Issue 34, p4601 

    A key risk factor in the development of atherosclerosis is a high concentration of serum low density lipoprotein (LDL)-cholesterol. The main purpose of this study was to assess the LDL and high density lipoprotein (HDL) content in human serum by employing near-infrared (NIR) spectroscopy and...

  • LOVASTATIN TO PREVENT ACUTE CORONARY EVENTS WITH AVERAGE CHOLESTEROL LEVELS. MacFarlane, Lori L.; Carek, Peter J. // Journal of Family Practice;Aug1998, Vol. 47 Issue 2, p91 

    The article discusses the role of lovastatin to prevent acute coronary events with average cholesterol levels. Cholesterol reduction with hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with and without preexisting cardiovascular disease reduces the incidence of acute...

  • Validation of the Modified Friedewald's Formula to Calculate Low-density Lipoprotein Cholesterol in Bangladeshi Population. PARVIN, M.; SAIEDULLAH, M.; KHAN, M. A. H.; RAHMAN, M. R.; ISLAM, M. S. // Journal of Bangladesh College of Physicians & Surgeons;Jul2012, Vol. 30 Issue 3, p141 

    Objective: A modification of Friedewald's formula was proposed to calculate LDL cholesterol in Bangladeshi population up to serum triglyceride concentration of 1000 mg/dL. The aim of this study was to validate the modification of Friedewald's formula in Bangladeshi population. Methods: Serum...

  • Implementation Strategies to Improve Non-HDL-Cholesterol Goal Attainment. Virani, Salim S. // Texas Heart Institute Journal;2012, Vol. 39 Issue 2, p228 

    The article discusses the strategies for improving non-high-density-lipoprotein cholesterol (non-HDL-C) goal attainment. It was suggested that non-HDL-C is a better cardiovascular risk marker compared with low-density-lipoprotein cholesterol (LDL-C). The reasons for lower non-HDL-C goal...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics